The company’s gross profit for the quarter was $3.5 million — up 31 percent from the year before. Fuse’s net income also increased by $630,524.
Fuse’s growth plan for 2023 and 2024 is to focus on the design and development of new orthopedic and spinal devices for commercialization and expand its national distribution footprint, according to an Aug. 15 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
